Skip to content

BIOGEN BELGIUM

Active Public limited companyfounded 1997active for 28 yearsCulliganlaan 2, 1831 Machelen (Brab.)KBO/BCE: BE 0462.285.469 subsidiary of .

Lifetime

21 annual accounts with figures on one time axis, 28 filings since 1998
peak of €115.9m in 2019
€84.7m▼ 3.6%
peak of €2.9m in 2020
€1.6m▼ 11.2%
peak of €15.4m in 2025
€15.4m▲ 11.9%
€10.0m▼ 19.8%
peak of 44.8 FTE in 2021
30.5 FTE▼ 12.1%
Board24 names since 2011all names
3 directors and 2 others
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
29-06-202632 days before the deadline
2025financial year
Staff from 34.7 FTE to 30.5 FTEPowers of attorney granted to and 06-10Power of attorney granted to 22-07Powers of attorney granted to and 23-06 resigns as director 02-06Debts from €12.5m to €10.0m

Key points

from the 2025 annual accounts

Equity

€15.4m ▲ 11.9%

BIOGEN BELGIUM has made a profit in every financial year since 2005.

Staff

30.5 FTE from 44.8 in 2021

Between 2021 and 2025, 32% of the full-time equivalents disappeared.

Payment terms

20 days to suppliers
Suppliers
40 to 20
Customers
42 to 36

BIOGEN BELGIUM pays its suppliers 20 days earlier than in 2024. Customers pay 6 days earlier.

Filings

28 annual accounts since 1998
AprilJune31 JulyOctober200020102020

The last five annual accounts were filed 8 to 32 days before the end of the period.

Position in the sector

€15.4m

More equity than 83% of companies in wholesale trade. Sector median €3.3m · 3,725 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as BIOGEN BELGIUM has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for BIOGEN BELGIUM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 15-09-2022
Director, since 22-09-2023
Director
  • consolidatedLEI register
Board & ownership

Recent changes

reappointed as statutory auditor Gazette deed
reappointed as director General meeting of 10-04-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0462285469
resigns as director Director discharge: · General meeting of 13-05-2025 · Gazette deed
All 78 events

Comparable companies

same main activity, similar in size and age
Company
BIOGEN BELGIUM Machelen (Brab.) €84.7m 3.2% 60.6% 30.5
Teva Pharma Belgium Antwerp €81.8m 3.8% 20.0% 32.5
PHARMA BASE Genk €75.2m 0.5% 12.0% 29
SONOVA BELGIUM Dilbeek €73.1m 4.3% 61.5% 15.1
BIOTRONIK BELGIUM Vilvoorde €39.5m 4.1% 14.5% 32
Boehringer Ingelheim Animal Health Belgium SA Ixelles €50.6m 1.4% 17.7% 38.4
MSD Animal Health Watermael-Boitsfort €52.7m 3.3% 14.6% 54.8
-10%0%10%20%€50m€500m€5bnBIOGEN BELGIUMEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as BIOGEN BELGIUM: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €21m and €44m, founded between 1990 and 1996.

Official details

Source: KBO
Status
Active since 29-12-1997Normal situation
Registered office
46 active companies are registered at this address4 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2024
Establishment unit
2.084.943.4371831 Machelen (Brab.), since 13-01-1998
Financial year end
31 December
Peppol
Reachable since 28-11-2025
Company details

Annual accounts 2025

€25.5m▼ 3.1%
Employeeson 31-12-2025
30▼ 11.8%
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Insights on BIOGEN BELGIUM

BIOGEN BELGIUM has existed since 1997. Turnover grew from €5.0m in 2005 to €84.7m in 2025 and staff from 6 to 30.5 full-time equivalents.

Solvency rose in 2025 from 52.5% to 60.6% because of the retained profit and lower debts.

In 2022, three directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOGEN BELGIUM

What is the company number of BIOGEN BELGIUM?
The company number of BIOGEN BELGIUM is 0462.285.469. The VAT number is the same number with BE in front: BE 0462.285.469.
Where is BIOGEN BELGIUM based?
The registered office is at Culliganlaan 2, 1831 Machelen (Brab.).Company details
What does BIOGEN BELGIUM do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of BIOGEN BELGIUM?
BIOGEN BELGIUM is a public limited company (NV).
When was BIOGEN BELGIUM founded?
BIOGEN BELGIUM was founded on 29-12-1997.
Is BIOGEN BELGIUM still active?
Yes, BIOGEN BELGIUM is an active enterprise in the KBO register.
How many employees does BIOGEN BELGIUM have?
BIOGEN BELGIUM had an average of 30.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does BIOGEN BELGIUM fall under?
In its 2024 annual accounts, BIOGEN BELGIUM states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of BIOGEN BELGIUM?
The turnover of BIOGEN BELGIUM was €84.7m in financial year 2025, according to the filed annual accounts.
Is BIOGEN BELGIUM profitable?
In financial year 2025, BIOGEN BELGIUM made a profit of €1.6m.
Where can I find the annual accounts of BIOGEN BELGIUM?
BIOGEN BELGIUM filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOGEN BELGIUM due?
BIOGEN BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.